Galapagos Initiates Second Phase I Clinical Trial for GLPG0259
News Sep 10, 2009
Galapagos NV has announced that it has initiated a second Phase I clinical trial for GLPG0259, a novel candidate drug being developed for rheumatoid arthritis (RA).
The new trial is based on the positive outcome of the first-in-human trial conducted earlier in 2009, which showed a good safety profile in healthy volunteers and pharmacokinetics (PK) supporting once daily oral dosing. The trial is aimed at assessing the combination of GLPG0259 with methotrexate (the current standard treatment for RA), and at extending the treatment duration.
Galapagos plans to conduct the multiple ascending dose study in 24 healthy volunteers using three 14-day dosing regimens. The results of the study will aid in the design of a Phase IIa study planned for 2010, where the efficacy of the novel candidate drug will be assessed in RA patients.
"We are pleased to progress our lead program based on our novel target discovery platform to this next step of clinical development," stated Onno van de Stolpe, Galapagos' CEO.
"This latest Phase I trial is designed to measure the longer term safety and tolerability profile of GLPG0259, while also assessing any interactions with the current standard treatment for RA. These results will provide information critical to the design of Phase II trials planned for next year, where we will evaluate the candidate drug's efficacy in treating RA patients."
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018